| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5926978 | American Heart Journal | 2014 | 6 Pages |
Abstract
In patients with STEMI undergoing PPCI, double (360 mg) ticagrelor LD failed to achieve a faster and more intense platelet inhibition as compared with the standard prasugrel LD. Intravenously administered aspirin allowed to achieve a very early inhibition of acid arachidonic pathway.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Guido MD, Benedetta MD, Renato MD, Angela MD, Rossella MD, Nazario MD, Letizia MD, Gian Franco MD, Rosanna MD, David MD,